FDA approves new ALS drug that costs $158,000 a year
September 30, 2022 at 13:12 PM EDT
Amylyx's new treatment for amyotrophic lateral sclerosis received funding raised during 2014's Ice Bucket Challenge.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |